- POSITIVE
Annual Revenue Aakaar Medical Technologies Mar-2026 Annual Revenue is Rs 68 Cr which is growth of 9.7% YoY.
- POSITIVE
Annual Net Profit Aakaar Medical Technologies Mar-2026 Annual Net Profit is Rs 7 Cr which is growth of 9.9% YoY.
NSE: AAKAAR
Aakaar Medical Technologies Live Share Price Today, Share Analysis and Chart
aboutAakaar Medical Technologies Ltd. is an Indian medical device manufacturer focused on providing products and services in the healthcare sector, particularly in renal care. The company specializes in the production of dialysis-related consumables and e... Read More
74.553.55(5.00%)
16,000
NSE Volume
NSE 02 Nov, 2026 10:50 AM (IST)
Please subscribe to view forecaster data
Aakaar Medical Technologies Stock Price Analysis
Day Price Range5.0% 1 Day return | 74.6 (LTP) 72.574.6 LowHigh |
|---|---|
Week Price Range16.8% 1 Week return | 74.6 (LTP) 63.674.6 LowHigh |
Month Price Range14.7% 1 Month return | 74.6 (LTP) 63.674.6 LowHigh |
52 Week Price Range-13.3% 1 Year return | 74.6 (LTP) 4690 LowHigh |
Competitors/Peers
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Aakaar Medical Technologies annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 |
|---|---|---|---|---|---|---|
27.3% | 67.8 | 61.8 | 46.3 | 32.9 | ||
Operating Exp. Ann. | 24.6% | 56.7 | 51.9 | 41.1 | 29.3 | |
Operating Profit Ann. | 43.3% | 10.3 | 9.7 | 5 | 3.5 | |
OPM Ann. % | 12.4% | 15.22% | 15.77% | 10.80% | 10.73% | |
25.3% | 58.6 | 53.7 | 42.4 | 29.8 | ||
EBITDA Ann. | 45.5% | 11.1 | 9.9 | 5.2 | 3.6 | |
EBITDA Ann. margin % | 14.2% | 16.40% | 16.05% | 11.15% | 11.02% | |
Interest Ann. | 65.1% | 1.8 | 1.7 | 1.1 | 0.4 | |
Depr. | 0% | 0.1 | 0.1 | 0.1 | 0.1 | |
PBT Ann. | 43.7% | 9.2 | 8.1 | 3.9 | 3.1 | |
Tax Ann. | 37.5% | 2.6 | 2 | 1 | 1 | |
44.2% | 6.6 | 6 | 2.9 | 2.2 | ||
Net Profit Ann. | 44.2% | 6.6 | 6 | 2.9 | 2.2 | |
NPM Ann. % | 14.7% | 9.91% | 9.80% | 6.22% | 6.56% | |
EPS Adj. latest Ann. | 46.3% | 4.7 | 4.3 | 2 | 1.5 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
9.7%
2Y CAGR
21%
3Y CAGR
27.3%
Net Profit Ann.
1Y CHG
10%
2Y CAGR
50.9%
3Y CAGR
44.2%
Operating Exp. Ann.
1Y CHG
9.2%
2Y CAGR
17.5%
3Y CAGR
24.6%
Aakaar Medical Technologies Technical Analysis
Aakaar Medical Technologies EMA & SMA
Bullish+8
8 bullish, 0 bearish
Bullish8
Bearish0
| 5 Day | 68.5 |
|---|---|
| 10 Day | 67.8 |
| 12 Day | 67.6 |
| 20 Day | 67.2 |
| 26 Day | 66.8 |
|---|---|
| 50 Day | 66 |
| 100 Day | 65.5 |
| 200 Day | 68.7 |
Aakaar Medical Technologies Delivery And Volume
Daily Avg. Delivery Volume %
29 Oct, 2026100.0%
Week90.9%
Month97.0%
Aakaar Medical Technologies Active Candlesticks
Short Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Aakaar Medical Technologies Resistance and Support
71.00
Pivot
| First Resistance | 71 |
|---|---|
| Second Resistance | 71 |
| Third Resistance | 71 |
| First Support | 71 |
|---|---|
| Second Support | 71 |
| Third Support | 71 |
| Day RSI | 59.5 |
|---|---|
| Day MACD | 0.8 |
| Day MFI | 64.5 |
| Day MACD Signal Line | 0.7 |
Aakaar Medical Technologies Beta
| 1 Month | 0.6 |
|---|---|
| 1 Year | -0.1 |
| 3 Month | -0.1 |
|---|---|
| 3 Year | - |
Aakaar Medical Technologies Price Change Analysis
↑14.7%
Over 1 Month
LowHigh
63.774.6
↑9.6%
Over 3 Months
LowHigh
48.274.6
↑43.2%
Over 6 Months
LowHigh
48.285.0
↓-13.3%
Over 1 Year
LowHigh
4690.0
Aakaar Medical Technologies Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| ALACRITY SECURITIES LTD | Bulk | Purchase | 27 Jun 2025 | 75 | 123,200 | NSE |
Aakaar Medical Technologies Corporate Actions
Aakaar Medical Technologies Board Meetings
Aakaar Medical Technologies past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
130 Oct 2026 | Quarterly Results and Other business matters | To approve financial results for September 30, 2026, and grant ESOPs to employees. |
225 May 2026 | Others | To consider Other business matters (Re-Scheduled) |
315 May 2026 | Audited Results & Others | To consider Other business matters. |
410 Nov 2025 | Quarterly Results | - |
Aakaar Medical Technologies - Company Profile
Aakaar Medical Technologies Management Structure
Aakaar Medical Technologies management structure with salaries, total experience, and qualifications.
Aakaar Medical Technologies Board of Directors
Aakaar Medical Technologies Board of directors with salaries, total experience, and qualifications.
Website: www.aakaarmedical.in
About the company - Business Profile
Aakaar Medical Technologies Ltd. is an Indian medical device manufacturer focused on providing products and services in the healthcare sector, particularly in renal care. The company specializes in the production of dialysis-related consumables and equipment, catering to the growing demand for affordable and accessible kidney treatment solutions in India and international markets.
Key Points
- Key facts: Aakaar Medical Technologies Ltd. was founded to address gaps in the medical technology market, specifically targeting nephrology and dialysis. The company is headquartered in Mumbai, India. It is listed on the SME platform of the BSE (Bombay Stock Exchange).
- Operations and resources: The company operates manufacturing facilities designed for the production of high-precision medical consumables. Its core focus includes the assembly and distribution of dialysis machines and the manufacturing of blood tubing sets and other renal care accessories.
- Market and significance: Aakaar plays a strategic role in the Indian MedTech ecosystem by contributing to the localization of medical devices. The company serves hospitals, dialysis centers, and government healthcare schemes, providing essential tools for the treatment of End-Stage Renal Disease (ESRD).
- Sustainability and innovation: The company focuses on cost-effective manufacturing processes to ensure affordability. Future goals involve expanding its product portfolio to include more advanced diagnostic and therapeutic tools.
- Business Model: Aakaar operates on a manufacturing and distribution model. It focuses on high-volume consumables which provide recurring revenue streams, complemented by capital equipment sales in the dialysis segment.
- Revenue Breakdown: For the financial year ended March 31, 2025, the company's revenue primarily originated from the sale of medical consumables and equipment. Specific segment and geographical data as per the annual report:
- Total Revenue (FY2024-25): ₹15.82 crore (compared to ₹13.45 crore in FY2023-24).
- Segment Performance: Revenue is heavily skewed towards Medical Consumables, accounting for approximately 85% of total sales, with Medical Equipment and services contributing the remaining 15%.
- Geographical Revenue: The domestic Indian market remains the primary source of revenue, contributing over 90% of total sales.
- Key Products:
- Dialysis Machines: Distribution and servicing of hemodialysis units.
- Blood Tubing Sets: In-house manufactured high-quality tubing for dialysis.
- Fistula Needles: Specialized needles used in the dialysis process.
- Dialyzers: Traded and distributed high-efficiency filters.
- Strategic Initiatives: The company is currently focused on scaling its manufacturing capacity for consumables to reduce reliance on third-party suppliers and improve margins. It has recently secured several regional government contracts for the supply of dialysis kits under public-private partnership models.
- Employee Overview: As of the latest annual report, the company employs approximately 120 full-time staff. Hiring trends have shown a 10% increase in technical and quality assurance roles over the last year to support expanded manufacturing lines.